Hexaminolevulinate Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the clinical use of hexaminolevulinate during breastfeeding. After instillation into the bladder, only about 7% of a dose is absorbed into the maternal bloodstream, so the amount of drug excreted into milk is expected to be minimal. Until more data become available, hexaminolevulinate should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Hexaminolevulinate
CAS Registry Number
140898-97-1
Drug Class
Breast Feeding
Lactation
Diagnostic Agents
Photosensitizing Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
